| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 327.89B | 316.40B | 312.36B | 275.78B | 223.62B |
| Gross Profit | 48.85B | 43.54B | 42.92B | 36.14B | 33.47B |
| EBITDA | 25.52B | 22.59B | 22.59B | 14.52B | 10.31B |
| Net Income | 8.22B | 6.12B | 5.30B | 1.31B | -5.18B |
Balance Sheet | |||||
| Total Assets | 347.26B | 332.10B | 338.63B | 356.23B | 329.55B |
| Cash, Cash Equivalents and Short-Term Investments | 51.92B | 35.30B | 33.26B | 30.04B | 24.80B |
| Total Debt | 30.78B | 37.22B | 32.62B | 84.30B | 74.09B |
| Total Liabilities | 113.38B | 111.86B | 109.57B | 149.85B | 134.68B |
| Stockholders Equity | 231.59B | 216.69B | 221.54B | 199.54B | 186.26B |
Cash Flow | |||||
| Free Cash Flow | 25.57B | -1.85B | 13.15B | -27.61B | -12.91B |
| Operating Cash Flow | 40.48B | 15.27B | 24.64B | -18.06B | -5.44B |
| Investing Cash Flow | -12.95B | -8.31B | 37.93B | 19.71B | -7.52B |
| Financing Cash Flow | -13.87B | -4.75B | -59.58B | 2.03B | -5.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥252.85B | 7.88 | ― | 3.36% | 4.89% | 43.96% | |
74 Outperform | ¥564.91B | 9.48 | 8.58% | 2.62% | 8.21% | 72.79% | |
72 Outperform | ¥153.98B | 18.60 | ― | 2.93% | 3.63% | 35.38% | |
70 Outperform | ¥789.30B | 48.05 | 7.20% | 2.41% | 3.37% | -62.36% | |
68 Neutral | ¥5.25T | 11.64 | 6.98% | 2.98% | 5.28% | 12.66% | |
68 Neutral | ¥215.21B | 29.76 | ― | 4.77% | -3.95% | -13.75% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |